Trials Sponsors Conditions Drugs Pricing

Conditions

Blood Pressure Measurement

Outcome Measures

Primary Outcomes (1)

Compare blood measurements obtained from the Philips Inflationary-based non-invasive blood pressure (iNIBP) system to the accepted auscultatory reference method.
Compare blood measurements (systolic blood pressure, diastolic blood pressure, and mean arterial pressure) obtained from the Philips Inflationary-based non-invasive blood pressure (iNIBP) system to the accepted auscultatory reference method.
Up to 8 weeks

Secondary Outcomes (1)

Compare the pulse rate obtained from the Philips Inflationary-based non-invasive blood pressure (iNIBP) system to the pulse rate obtained from a refence PPG obtained from a pulse oximetry sensor.
Up to 8 weeks

Study Arms (1)

Participants will be 3 to 85 years of age with an upper arm circumference within 14 - 43 cm.

Other: Blood Pressure Measurement

Interventions

Blood Pressure MeasurementOther

The Philips inflationary based algorithm of the IntelliVue X3 Monitor will be used to measure systolic blood pressure, diastolic blood pressure, and mean arterial pressure compared to the ausculatory reference method.

Participants will be 3 to 85 years of age with an upper arm circumference within 14 - 43 cm.

Eligibility Criteria

Age3 Years - 85 Years

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

The study population will include a minimum of 85 to 150, pediatric and adult volunteers.

You may qualify if:

Participants must be 3 to 85 years of age.

Sponsors & Collaborators

Philips Clinical & Medical Affairs Global
Industrylead

Study Sites (1)

Element Materials Technology

Louisville, Colorado, 80027, United States

RECRUITING

Monica Rabanal, NPCONTACT303-926-5432 monica.rabanal@element.com

Monica Rabanal, NPPRINCIPAL INVESTIGATOR

Central Study Contacts

Jessica Rodriguez

CONTACT

857-275-9668 Jessica.Rodriguez_1@philips.com

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: PROSPECTIVE
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 22, 2026

First Posted

October 28, 2026

Study Start

October 15, 2026

Actual (reported)

Primary Completion

December 31, 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Philips Inflationary-Based Non-Invasive Blood Pressure Validation Study

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Participants will be 3 to 85 years of age with an upper arm circumference within 14 - 43 cm.

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Participants will be 3 to 85 years of age with an upper arm circumference within 14 - 43 cm.

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations